Status:
UNKNOWN
Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
Lead Sponsor:
Society for Advancement of Coronary Intervention Research
Conditions:
Stable Angina Pectoris
Unstable Angina Pectoris
Eligibility:
All Genders
20-80 years
Phase:
PHASE4
Brief Summary
The utilization of paclitaxel-eluting coronary stents in small vessel diseases is effective in reducing both repeat revascularization and major adverse cardiac events within two year follow-up. To eva...
Eligibility Criteria
Inclusion
- Age ≥20 years and are able to undergo CABG
- Females who are not pregnant
- Patients who present with angina symptoms or myocardial ischemia
- Patients available for post-procedural observation and coronary angiography at 24 months
- Patients who have signed patient informed consent
- Lesion which is eligible for only one 2.5mm paclitaxel-eluting stent
- De novo lesion or non-stented restenosed lesion
Exclusion
- Patients contraindicated for antiplatelet therapy or anticoagulant therapy
- Patients with significant allergic reaction to contrast medium
- Chronic total occlusion
- Lesion with TIMI0
- Lesion which is needed more than two stents
- Patients with chronic renal failure (SCr\>3.0mg/dl) -
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00955214
Start Date
April 1 2009
End Date
August 1 2012
Last Update
June 10 2010
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Japanese red cross nagoya daiichi hospital
Nagoya, Aichi-ken, Japan, 4538511
2
Higashi Cardiovascular clinic
Toyohashi, Aichi-ken, Japan, 4400836
3
Toyohashi Heart Center
Toyohashi, Aichi-ken, Japan, 4418530
4
Kokura memorial hospital
Kitakyushu, Fukuoka, Japan, 8028555